Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

CoraDoc vs LillyDirect Foundayo

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade C · #191

CoraDoc

Shoppers able to prepay a full 6-month program upfront (via Afterpay/Klarna/Affirm splits if needed) for the lowest per-month rate.

Visit CoraDoc
VS
Grade C · #196

LillyDirect Foundayo

Patients who want an FDA-approved, manufacturer-direct oral GLP-1 rather than a compounded injectable.

Visit LillyDirect Foundayo

The verdict

Too close to callGrade C vs C

CoraDoc and LillyDirect Foundayo tie on the Cost-Efficiency Index at 63/100, so neither wins outright on the numbers. For most shoppers we'd start with CoraDoc (ranked #191, a hair above #196) — Shoppers able to prepay a full 6-month program upfront (via Afterpay/Klarna/Affirm splits if needed) for the lowest per-month rate. But LillyDirect Foundayo is a genuine coin-flip alternative here.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs CoraDoc.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

69
45

Price Transparency

78
54

Nationwide Access

24
86

Formulation Options

66
69

Clinical Oversight

80
76

Contract Flexibility

61
55

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecCoraDocLillyDirect Foundayo
Cost-Efficiency Index63/10063/100
Semaglutide / mo$99/mo (starting dose, 6-month plan, compounded)Not disclosed
Tirzepatide / mo$149/mo (6-month plan, compounded)Not disclosed
Semaglutide / yr (modeled)$1,188
Tirzepatide / yr (modeled)$1,788
CoverageCoverage not publishedAll 50 states
Oral / sublingualNoYes
Brand-name accessCompounded onlyYes
Rank here#191#196

CoraDoc

63/100

Where the value is

  • Four named, board-certified providers disclosed by name — unusually transparent for this tier of provider
  • LegitScript certified with a published Triple Free Promise (visit, shipping, supplies)
  • Nationwide coverage including Hawaii

The tradeoffs

  • The headline $99/mo price is a 6-month PREPAID program, not a month-to-month rate — 'no subscription' in CoraDoc's marketing means one large upfront payment, not low commitment, and this is easy to misread
  • The actual total dollar amount charged upfront is not published in plain text — only Afterpay/Klarna 4-payment splits are shown instead of a lump total
Visit CoraDoc

Full CoraDoc review →

LillyDirect Foundayo

63/100

Where the value is

  • First-party Eli Lilly program -- highest possible manufacturer authenticity
  • FDA-approved branded drug (orforglipron), not an unapproved compounded formulation
  • Published self-pay starting price ($149) via savings card

The tradeoffs

  • Not semaglutide or tirzepatide -- a different molecule (orforglipron), so not directly comparable on this list
  • The $149 price is tied to a specific Savings Card program with its own terms, not an unconditional list price
Visit LillyDirect Foundayo

Full LillyDirect Foundayo review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons